Table: SymBio Pharmaceuticals - 9-MTH parent results

SymBio Pharmaceuticals

10/11/2020 06:30

Nov 10 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Sep 30, 2020        Sep 30, 2019       Dec 31, 2020  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales             2.33                2.01               3.04      
                 (+16.2 pct)         (-33.8 pct)        (+7.2 pct)   
  Operating       loss 3.14           loss 3.54         loss 4.59    
  Recurring       loss 3.22           loss 3.64         loss 4.66    
  Net             loss 2.69           loss 3.64         loss 3.80    
  EPS          loss 84.59 yen      loss 161.33 yen   loss 116.13 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T